Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluid Strategies in Hepatobiliary Surgery
NCT03923816Phase 2Unknown
- Sponsor
- Assiut University
- Start
- Oct 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of lactated ringer's solution in hepatobiliary disease (2 arms), sponsored by Assiut University. Primary endpoint: Serum Glutamic Pyruvic Transaminase change. Status: unknown.
02
Drugs
lactated ringer's solution
03
Conditions
hepatobiliary disease
Beyond the preview
Go deeper on NCT03923816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03923816.